Technical Analysis for PTGX - Protagonist Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 25.22 | -1.37% | -0.35 |
PTGX closed down 1.37 percent on Thursday, April 18, 2024, on 74 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 2
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | -1.37% |
| Alert | Time |
|---|---|
| Rose Above Lower Bollinger Band | about 19 hours ago |
| 60 Minute Opening Range Breakout | about 19 hours ago |
| Fell Below Previous Day's Low | about 20 hours ago |
| Down 1% | about 20 hours ago |
| 60 Minute Opening Range Breakdown | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Autoimmune Disease Inflammatory Bowel Disease Ulcerative Colitis Ulcer Abdominal Pain Colitis Crohn's Disease Chemical Entities Hepcidin
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Autoimmune Disease Inflammatory Bowel Disease Ulcerative Colitis Ulcer Abdominal Pain Colitis Crohn's Disease Chemical Entities Hepcidin
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 33.34 |
| 52 Week Low | 13.72 |
| Average Volume | 587,420 |
| 200-Day Moving Average | 21.73 |
| 50-Day Moving Average | 28.43 |
| 20-Day Moving Average | 27.65 |
| 10-Day Moving Average | 27.13 |
| Average True Range | 1.06 |
| RSI (14) | 31.51 |
| ADX | 16.96 |
| +DI | 15.62 |
| -DI | 24.60 |
| Chandelier Exit (Long, 3 ATRs) | 26.56 |
| Chandelier Exit (Short, 3 ATRs) | 28.34 |
| Upper Bollinger Bands | 29.67 |
| Lower Bollinger Band | 25.62 |
| Percent B (%b) | -0.1 |
| BandWidth | 14.65 |
| MACD Line | -0.70 |
| MACD Signal Line | -0.37 |
| MACD Histogram | -0.3261 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 26.10 | ||||
| Resistance 3 (R3) | 26.18 | 25.97 | 25.95 | ||
| Resistance 2 (R2) | 25.97 | 25.74 | 25.93 | 25.90 | |
| Resistance 1 (R1) | 25.59 | 25.61 | 25.49 | 25.51 | 25.85 |
| Pivot Point | 25.38 | 25.38 | 25.33 | 25.34 | 25.38 |
| Support 1 (S1) | 25.01 | 25.16 | 24.90 | 24.93 | 24.59 |
| Support 2 (S2) | 24.80 | 25.02 | 24.76 | 24.54 | |
| Support 3 (S3) | 24.42 | 24.80 | 24.49 | ||
| Support 4 (S4) | 24.34 |
